A 6-week, multicentre, prospective, open-label, observational study to evaluate the efficacy of tadalafil in men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Therapeutic Use
- Acronyms TadaLutsEd
- 05 Dec 2015 New trial record